Abstract:The effects of long-term administration of bovine growth hormone (GH) on pre-pubertal mammogenesis and subsequent milk production were examined in pasture-fed dairy heifers. Purified bovine GH (specific activity 0·78 i.u. per mg) was administered daily for 21 weeks (0·6 mg GH per kg M 0·75) to one member of each of 12 sets of twins from 3·5 (range 2·5 to 4-5) months of age. GH administration resulted in a significantly smaller mammary gland compared with control heifers at slaughter at the end of treatment (71… Show more
“…Specifically, GH acts on mammary stromal and epithelial tissues in rats to induce the differentiation of ductal epithelia into terminal end buds (TEBs) and alveolar structures and promotes the morphogenesis of the TEBs in the mammary fat pad (Walden et al 1998). GH administration to peri-pubertal heifers (Sejrsen et al 1986, Sandles et al 1987, Purup et al 1993) and lambs (McFadden et al 1990) similarly increases the amount of parenchymal tissue, although overall mammary size may not be increased, and immunization of heifers against GHRH similarly impairs pubertal mammary development (Sejrsen et al 1999). Increased milk yield resulting from peripubertal GH administration has not, however, been observed in numerous studies in heifers (reviewed by Sejrsen et al 1999).…”
GH, as its name suggests, is obligatory for growth and development. It is, however, also involved in the processes of sexual differentiation and pubertal maturation and it participates in gonadal steroidogenesis, gametogenesis and ovulation. It also has additional roles in pregnancy and lactation. These actions may reflect direct endocrine actions of pituitary GH or be mediated by its induction of hepatic or local IGF-I production. However, as GH is also produced in gonadal, placental and mammary tissues, it may act in paracrine or autocrine ways to regulate local processes that are strategically regulated by pituitary GH. The concept that GH is an important modulator of female reproduction is the focus of this review.
“…Specifically, GH acts on mammary stromal and epithelial tissues in rats to induce the differentiation of ductal epithelia into terminal end buds (TEBs) and alveolar structures and promotes the morphogenesis of the TEBs in the mammary fat pad (Walden et al 1998). GH administration to peri-pubertal heifers (Sejrsen et al 1986, Sandles et al 1987, Purup et al 1993) and lambs (McFadden et al 1990) similarly increases the amount of parenchymal tissue, although overall mammary size may not be increased, and immunization of heifers against GHRH similarly impairs pubertal mammary development (Sejrsen et al 1999). Increased milk yield resulting from peripubertal GH administration has not, however, been observed in numerous studies in heifers (reviewed by Sejrsen et al 1999).…”
GH, as its name suggests, is obligatory for growth and development. It is, however, also involved in the processes of sexual differentiation and pubertal maturation and it participates in gonadal steroidogenesis, gametogenesis and ovulation. It also has additional roles in pregnancy and lactation. These actions may reflect direct endocrine actions of pituitary GH or be mediated by its induction of hepatic or local IGF-I production. However, as GH is also produced in gonadal, placental and mammary tissues, it may act in paracrine or autocrine ways to regulate local processes that are strategically regulated by pituitary GH. The concept that GH is an important modulator of female reproduction is the focus of this review.
“…This decrease was brought about by a diminished feed intake which was significant during the 4th wk of lactation in LACT and GEST-LACT sows (Farmer et al 1992). A decrease in extraparenchymal tissue was also reported in GH-treated (Sandles et al 1987;Purup et al 1993) and in GRF-injected prepubertal heifers (Ringuet et al 1989) and was said to be due to the lypolytic action of GH. For personal use only.…”
Section: Farmer Et Al -Grf and Mammary Gland Development 337mentioning
confidence: 84%
“…Hence, milk production is a function of alveolar cell number and of the metabolic activity of these cells along with the metabolic support provided by other body tissues. Previously published results have reported either no change (Purup et al 1993) or an increase (Sandles et al 1987;Ringuet et al 1989) in mammary parenchyma of peripubertal heifers receiving GH or GRF. Increases in parenchymal protein (Purup et al 1993) and in total parenchymal DNA (Sandles et al 1987) have also been observed in GH-treated heifers.…”
Section: Farmer Et Al -Grf and Mammary Gland Development 337mentioning
confidence: 85%
“…Previously published results have reported either no change (Purup et al 1993) or an increase (Sandles et al 1987;Ringuet et al 1989) in mammary parenchyma of peripubertal heifers receiving GH or GRF. Increases in parenchymal protein (Purup et al 1993) and in total parenchymal DNA (Sandles et al 1987) have also been observed in GH-treated heifers. The possible roles of GH and GRF on lactation of sows has received much attention over the past few years (Farmer 1996).…”
Section: Farmer Et Al -Grf and Mammary Gland Development 337mentioning
confidence: 85%
“…Administration of GH during gestation and lactation, or during lactation only, increased milk production of sows by 16% or more (Spence et al 1984;Harkins et al 1989). Exogenous GRF during gestation increased milk production of ewes (Kann et al 1988), whereas it had no effect on milk production of sows (Farmer et al 1992).…”
. 1997. Mammary gland development of sows injected with growth hormone-releasing factor during gestation and(or) lactation. Can. J. Anim. Sci. 77: 335-338. Twenty-four gilts received s.c. injections of saline or growth hormone-releasing factor (GRF) in late gestation and(or) lactation. Sows were sacrificed on day 30 of lactation and functional mammary glands were excised for chemical analyses. Weight of parenchymal (P = 0.004) and extraparenchymal tissues (P = 0.002) were decreased with GRF injections during lactation. Parenchymal mass per milligram of DNA also decreased (P = 0.025) with GRF in lactation while parenchymal DNA concentration increased (P = 0.03). Exogenous GRF given to sows during lactation therefore decreased total parenchymal mass, increased cell density and decreased mammary cell size.Key words: Sow, mammary gland, growth hormone-releasing factor Farmer, C., Pelletier, G., Brazeau, P. et Petitclerc, D. 1997. L'effect d'un apport de somatocrinine en gestation et(ou) en lactation sur le développement mammaire des truies. Can. J. Anim. Sci. 77: 335-338. Vingt-quatre cochettes ont reçu des injections s.c. de saline ou de somatocrinine en fin de gestation et(ou) en lactation. Les truies ont été sacrifiées au jour 30 de lactation et les glandes mammaires ont été recueillies pour analyses biochimiques. Les poids des tissus parenchymateux (P = 0.004) et extraparenchymateux (P = 0.002) ont diminué suite au traitement en lactation. Le rapport de tissu parenchymateux sur l'ADN total a aussi diminué (P = 0.025) avec le traitement en lactation, mais la concentration d'ADN dans le parenchyme a augmenté (P = 0.03). Un apport de somatocrinine en lactation a donc diminué la masse totale de tissu parenchymateux, augmenté la densité cellulaire et diminué la taille des cellules mammaires.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.